Nadler Financial Group, Inc. Cybin Inc. Transaction History

Nadler Financial Group, Inc.

  • $850 Million
  • Q2 2024

A detailed history of Nadler Financial Group, Inc. transactions in Cybin Inc. stock. As of the latest transaction made, Nadler Financial Group, Inc. holds 98,700 shares of CYBN stock, worth $872,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,700
Previous 98,700 -0.0%
Holding current value
$872,508
Previous $40,000 35.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024
BUY
$0.3 - $0.46 $16,500 - $25,300
55,000 Added 125.86%
98,700 $40,000
Q3 2022

Oct 31, 2022
BUY
$0.48 - $1.11 $20,976 - $48,507
43,700 New
43,700 $21,000

Others Institutions Holding CYBN

# of Institutions
102
Shares Held
270M
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.47B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Nadler Financial Group, Inc. Portfolio

Follow Nadler Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nadler Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email